Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Hayfin Capital Management

Investor type Venture Capital
Founders Mark Tognolini Timothy Flynn

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$176M
Portfolio companies 7
Rounds per year 0.54
Lead investments 3
Exits 4
Key employees 19

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Life Science
Summary

Hayfin Capital Management is the famous VC, which was founded in 2009. The company was established in Europe in United Kingdom. The main office of represented VC is situated in the London.

The real fund results show that this VC is 47 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 50 - 100 millions dollars. The top activity for fund was in 2018. Comparing to the other companies, this Hayfin Capital Management performs on 4 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2013.

The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Hayfin Capital Management, startups are often financed by Montreux Equity Partners, Oyster Capital Partners, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Oyster Capital Partners, Montreux Equity Partners, Grovepoint Capital. In the next rounds fund is usually obtained by VentureSouth.

Among the most popular portfolio startups of the fund, we may highlight GC Aesthetics, NKD, Avadim Health. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of more than 20 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Life Science.

This organization was formed by Mark Tognolini, Timothy Flynn. Besides them, we counted 19 critical employees of this fund in our database.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
401 Capital Partners Canada, Oakville, Ontario
Angel Street Capital Providence, Rhode Island, United States
Atrium Ventures British Columbia, British Columbia, Canada
Crescent Enterprises Venture Capital Sharjah, Sharjah Emirate, United Arab Emirates
HealthStart India, Noida, Uttar Pradesh
Keiretsu Forum Spain Barcelona, Catalonia, Spain
McDonald Partners Cleveland, Ohio, United States
Mic Invest -
OLMA Private Equity Fund County Dublin, Dublin, Ireland
Pan-China(Xiamen) Consulting Co.,Ltd -
Reach LLC Boston, Massachusetts, United States
Rhino Ventures (Formerly Vancouver Founder Fund) British Columbia, Canada, Vancouver
Robot Ventures California, San Francisco, United States
Sapient Capital Partners Canada, Ontario, Toronto
Senshu Ikeda Holdings Japan, Osaka, Osaka Prefecture
Strada Education Innovation Fund Indiana, Indianapolis, United States
The Wolfen Group -
United Fund China, Hangzhou, Zhejiang
Wing -
Xinwen Ziben Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ADMA Biologics

Biotechnology
Health Care
Medical
$150M24 Mar 2022 New Jersey, United States

KEO World

Financial Services
FinTech
Lending
Small and Medium Businesses
$500M01 Feb 2022 Miami, Florida, United States

Amicus Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$400M17 Jul 2020 New Jersey, United States

MiMedx Group

Biotechnology
Health Care
Manufacturing
Marketing
Medical
Medical Device
Wellness
02 Jul 2020 Marietta, Georgia, United States

GC Aesthetics

Health Care
Medical Device
$97M30 Oct 2018 Dublin

Avadim Health

Biotechnology
Consumer Goods
Health Care
Life Science
Medical
$60M11 Oct 2018 Asheville, North Carolina, United States

NKD

E-Commerce
Fashion
Lifestyle
$29M20 Jan 2015 Bayern, Bavaria, Germany

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Hayfin Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: